Jie-jing Qian
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia.
Journal: Journal of hematology & oncology
Published: August 22, 2022
A real-world study of infectious complications of venetoclax combined with decitabine or azacitidine in adult acute myeloid leukemia.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: December 14, 2021
The first report of complete remission following treatment with venetoclax plus prednisone in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Journal: Annals of hematology
Published: July 14, 2021
CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemia.
Journal: American journal of hematology
Published: August 25, 2020
An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: March 15, 2020
CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study.
Journal: Cancer medicine
Published: November 19, 2019
Venetoclax and arsenic showed synergistic anti-leukemia activity in vitro and in vivo for acute myeloid leukemia with the NPM1 mutation.
Journal: American journal of hematology
Published: September 29, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026